Feds to Pharma: Talking Smack About Biosimilars a No-No

]]>(MedPage Today) -- The FDA and the Federal Trade Commission (FTC) on Monday announced a joint project to crack down on "false or misleading" marketing claims about biosimilars, with the implicit aim to boost sales of the latter.Spurred by biosimilars...